Literature DB >> 11922567

Prevalence of autonomic dysfunction in cirrhotic and noncirrhotic portal hypertension.

Manisha Rangari1, S Sinha, Dharmesh Kapoor, Jagdish C Mohan, Shiv K Sarin.   

Abstract

OBJECTIVE: Autonomic dysfunction is common in patients with cirrhosis of the liver, but more so in patients with decompensated state, and is associated with increased mortality. We evaluated the presence and extent of autonomic dysfunction in patients with extrahepatic portal venous obstruction (EHPVO) and noncirrhotic portal fibrosis (NCPF), diseases with relatively preserved liver functions.
METHODS: Heart rate variability in response to standing, deep breathing, and Valsalva maneuver and blood pressure response to sustained handgrip and standing were studied in 18 patients with EHPVO (13 mol/L, 5 F, mean age 15.2 +/- 6 yr), 12 patients with NCPF (5 mol/L, 7 F, mean age 26.4 +/- 8 yr), 15 patients with cirrhosis (7 mol/L, 8 F, mean age 12.6 +/- 6 yr), and 17 healthy controls (11 mol/L, 6 F, mean age 18.6 +/- 3 yr). Time-domain parameters of heart rate variability on 24-h ambulatory monitoring were assessed in all the patients.
RESULTS: Autonomic dysfunction was observed in 67% of EHPVO, 25% of NCPF, and 80% of cirrhotic subjects but none of the healthy controls (p < 0.05). Four of five time-domain heart rate variability indices showed significant abnormalities in patients with EHPVO (p < 0.05) and cirrhosis (p < 0.05), when compared with patients with NCPF and healthy controls.
CONCLUSIONS: Autonomic dysfunction is frequently encountered in patients with EHPVO and cirrhosis, and the presence of autonomic dysfunction in patients with noncirrhotic portal hypertension suggests a primary role of portal hypertension per se in the dysfunction.

Entities:  

Mesh:

Year:  2002        PMID: 11922567     DOI: 10.1111/j.1572-0241.2002.05551.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  14 in total

1.  Diastolic dysfunction characterizes cirrhotic cardiomyopathy.

Authors:  Piyush O Somani; Qais Contractor; Ajay S Chaurasia; Pravin M Rathi
Journal:  Indian Heart J       Date:  2014-07-23

2.  Prevalence and clinical presentation of cirrhotic cardiomyopathy: A single centre experience from southern India.

Authors:  Ravi Bokarvadia; Mayank Jain; Chandankumar Kedarisetty; Joy Varghese; Jayanthi Venkataraman
Journal:  Indian J Gastroenterol       Date:  2019-05-21

3.  Cirrhotic cardiomyopathy is less prevalent in patients with Budd-Chiari syndrome than cirrhosis of liver.

Authors:  Akash Shukla; Pratin Bhatt; Deepak Kumar Gupta; Tejas Modi; Jatin Patel; Milind Phadke; Krantikumar Rathod; Megha Meshram; S J Bhatia
Journal:  Indian J Gastroenterol       Date:  2018-01-24

Review 4.  Idiopathic portal hypertension and extrahepatic portal venous obstruction.

Authors:  Rajeev Khanna; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2018-02-20       Impact factor: 6.047

5.  Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment.

Authors:  Shiv Kumar Sarin; Ashish Kumar; Yogesh Kumar Chawla; Sanjay Saran Baijal; Radha Krishna Dhiman; Wasim Jafri; Laurentius A Lesmana; Debendranath Guha Mazumder; Masao Omata; Huma Qureshi; Rizvi Moattar Raza; Peush Sahni; Puja Sakhuja; Mohammad Salih; Amal Santra; Barjesh Chander Sharma; Praveen Sharma; Gamal Shiha; Jose Sollano
Journal:  Hepatol Int       Date:  2007-09-11       Impact factor: 6.047

6.  A disturbance of the gastric myoelectric activity in post-operative patients with biliary atresia.

Authors:  Masahiro Ohtaki; Minoru Yagi; Masayuki Kubota; Shinji Homma
Journal:  Pediatr Surg Int       Date:  2004-01-14       Impact factor: 1.827

Review 7.  Cardiopulmonary complications in chronic liver disease.

Authors:  Soren Moller; Jens H Henriksen
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

8.  Impaired gallbladder motility and delayed orocecal transit contribute to pigment gallstone and biliary sludge formation in beta-thalassemia major adults.

Authors:  Piero Portincasa; Antonio Moschetta; Massimo Berardino; Agostino Di-Ciaula; Michele Vacca; Giuseppe Baldassarre; Anna Pietrapertosa; Rosario Cammarota; Nunzia Tannoia; Giuseppe Palasciano
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

9.  Atrial Fibrillation is a Risk Factor for Worse Outcomes in Patients with End Stage Liver Disease.

Authors:  Zia Khan Muhammad; U Khan Muhammad; U Khan Safi; Alharbi Anas; Osman Mohammed; Pratik Agrawal; Mina M Benjamin; Kinjan Patel; Sudarshan Balla; Muhammad Bilal Munir
Journal:  J Atr Fibrillation       Date:  2020-02-28

10.  Heart rate variability analysis in general medicine.

Authors:  Yi Gang; Marek Malik
Journal:  Indian Pacing Electrophysiol J       Date:  2003-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.